Magnetic resonance imaging in the diagnosis of nonpalpable breast cancer

S S Vatankha; S A Saryev

doi:10.17750/KMJ2017-34

Kazan medical journal ›› 2017, Vol. 98 ›› Issue (1) : 34 -37. DOI: 10.17750/KMJ2017-34

Theoretical and clinical medicine

research-article

Magnetic resonance imaging in the diagnosis of nonpalpable breast cancer

Author information +

History +

PDF

Abstract

Aim. To analyze sensitivity of magnetic resonance imaging (MRI) in the diagnosis of breast cancer when used after mammography and breast ultrasound.

Methods. The study included 70 patients with nonpalpable breast lesions who had changes of breast tissue found at previous studies (mammography and breast ultrasound). MRI was performed with the use of Siemens Magnetom Avanto with magnetic field 1.5 Tl.

Results. Most frequently nonpalpable lesions were diagnosed in 45 to 60-year old patients (60%), a little rarer - in 39 to 45-year old patients (22.9%), in patients at the age of 61 to 69 - in 10.0% (7 patients). 7.1% patients were over 70. All first detected nonpalpable lesions of breast were biopsied for morphological verification. With the combined use of mammography, sonography, MRI and stereotactic biopsy the diagnosis was made in 100% patients. MRI with contract enhancement showed no relation between sensitivity, specificity and reliability and density of breast tissues.

Conclusions. MRI is considered a highly sensitive method of diagnosis and identification of changes found at mammography and breast ultrasound.

Keywords

breast cancer / diagnosis / magnetic resonance imaging / mammography / sensitivity

Cite this article

Download citation ▾

S S Vatankha, S A Saryev. Magnetic resonance imaging in the diagnosis of nonpalpable breast cancer. Kazan medical journal, 2017, 98(1): 34-37 DOI:10.17750/KMJ2017-34

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Алиев Д.А., Джафаров Р.Д., Наджафов Т.А. и др. Сравнительное изучение показателей 5-летней выживаемости у больных люминальным А и люминальным Б РМЖ. Azərbaycan onkologiya və hematologiya jurnalı. 2014; (1): 102-104.

[2]	Берштейн Л.М. Рак гормонозависимых тканей в системе основных неинфекционных заболеваний человека. СПб.: Эскулап. 2009; 180 с.

[3]	Бойков И.В. Руководство по лучевой диагностике заболеваний молочных желёз. Под ред. Г.Е. Труфанова. СПб.: ЭЛБИ-СПб. 2009; 351 с.

[4]	Куликов Е.П., Загадаев А.П. Непальпириумые опухоли молочных желёз. М.: ГЭОТАР-Медиа. 2013; 152 с.

[5]	Мальчугина Е.Л., Диомидова В.Н., Агафонкина Т.В. Маммосцинтиграфия в алгоритме лучевой диагностики рака молочной железы. Вестн. Чуваш. гос. ун-та. 2013; (3): 320-327.

[6]	Труфанов Г.Е. Руководство по лучевой диагностике заболеваний молочных желёз. СПб.: ЭЛСБИ-СПб. 2009; 229 с.

[7]	Kim S.J., Tanei T., Morimoto K. et al. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin. Cancer Res. 2009; 15: 4234-4241. doi: 10.1158/1078-0432.CCR-08-1479

[8]	Lee J., Choi H. Diffusion-weighted imaging in breast malignancies: Comparison of different b-value. Eur. Radiology. 2008; 18 (1): 96.

[9]	Lopez J., Bassett L. Invasive lobular carcinoma of the breast: spectrum of mammographic, US, and MR imaging findings. Radiographics. 2009; (1): 165-176. doi: 10.1148/rg.291085100

[10]	Peters N.H., Borel Rinkes I.H., Mali W.P. et al. Breast MRI in nonpalpable breast lesions: a randomized trial with diagnostic and therapeutic outcome - MONET - study. Radiology. 2007; 8: 149-155. doi: 10.1186/1745-6215-8-40

[11]	Peters N.H., Borel Rinkes I.H., Zuithoff N.P. et al. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology. 2008; 246: 116-124. doi: 10.1148/radiol.2461061298